Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hour.

Acknowledgment of Support

This educational activity is supported by educational grants from AstraZeneca; Athenex; Daiichi Sankyo, Inc.; Novartis Pharmaceuticals Corporation; Seattle Genetics, Inc.; Servier Pharmaceuticals LLC; and Taiho Oncology, Inc.

Community Practice Connections™ 4th Annual School of Nursing Oncology™

Release Date: October 30, 2020
Expiration Date: October 30, 2021

Activity Overview

Rapid advancements in the field of oncology nursing are raising the bar for the care of your patients, and this online, on-demand program is an ideal format to get up-to-date on recent advances. Nursing oncology is a perpetually evolving field, with numerous advancements in the pharmacologic treatment of cancer as well as complementary therapies to help mitigate disease symptoms and potential treatment-related adverse events emerging at a rapid pace. Throughout this program, video interviews with our expert faculty will provide insight into the evolving treatment landscape in cancer care, with a focus on lung cancer, melanoma, and kidney cancer. Emerging data will also be discussed in the context of patient case scenarios to help you integrate the latest treatment options into the care of your patients.

Acknowledgement of Commercial Support

This educational activity is supported by educational grants from AstraZeneca; Athenex; Daiichi Sankyo, Inc.; Novartis Pharmaceuticals Corporation; Seattle Genetics, Inc.; Servier Pharmaceuticals LLC; and Taiho Oncology, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward nurses interested in the management of patients with cancer. Other health care professionals interested in the management of patients with cancer are also invited to attend.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Evaluate recent therapeutic advancements in the treatment of solid and hematologic malignancies.
  • Outline the rationale for different assays used in guiding treatment selection for various malignancies.
  • Summarize treatment-related adverse events likely to occur during treatment for cancer.
  • Integrate best practices into the plan of care to manage adverse events associated with cancer therapies.
  • Select evidence-based supportive care and counseling strategies for patients throughout the continuum of cancer management.
  • Analyze elements of clinical trial design in the context of enhancing patient communication and clinical trial enrollment.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Grace Cherry, MSN, RN, NP
Grace Cherry, MSN, RN, NP
Oncology Nurse Practitioner
UCLA Melanoma Program
Los Angeles. CA

Disclosures: Consultant: Array BioPharma; Speakers Bureau: Merck and Company, Novartis Pharmaceuticals Corporation.

Beth Sandy, MSN, CRNP
Beth Sandy, MSN, CRNP
Thoracic Medical Oncology Nurse Practitioner
Abramson Cancer Center
Hospital of the University of Pennsylvania
Philadelphia, PA

Disclosures: Speakers Bureau: AstraZeneca Pharmaceuticals, Helsinn Therapeutics, Merck and Company, Takeda Pharmaceutical Company.

Laura S. Wood, MSN, OCN
Laura S. Wood, MSN, OCN
Renal Cancer Research Coordinator
Taussig Cancer Center-Cleveland Clinic
Cleveland, OH

Disclosures: Consultant: Eisai Pharmaceuticals; Speakers Bureau: Bristol Myers Squibb, Merck and Company, Pfizer.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By